Skip to main content

Aviance Capital Partners, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1542383 NAPLES, FL

Position in GILD

as of Jun 30, 2026 · filed Jul 31, 2026
Position Value
$700,807
+$34,061 QoQ
Shares Held
5,547
+15.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#1,228
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Aviance Capital Partners, LLC holds $78,033,539 across 10 Drug Manufacturers - General names. GILD ranks #9 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in GILD

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $700,807 5,547
2026-03-31 $666,746 4,784
2025-12-31 $619,346 5,046
2025-09-30 $562,437 5,067
2025-06-30 $531,732 4,796
2025-03-31 $584,676 5,218
2024-12-31 $1,930,717 20,902
2024-09-30 $1,560,765 18,616
2024-06-30 $1,199,165 17,478
2024-03-31 $1,335,347 18,230
2023-12-31 $1,430,717 17,661
2023-09-30 $1,357,163 18,110
2023-06-30 $1,434,118 18,608
2023-03-31 $1,505,822 18,149
2022-12-31 $1,535,427 17,885
2022-09-30 $1,027,323 16,653
2022-06-30 $1,010,593 16,350
2022-03-31 $748,653 12,593
2021-12-31 $1,082,469 14,908
2021-09-30 $1,061,161 15,192
2021-06-30 $1,084,131 15,744
2021-03-31 $1,077,446 16,671
2020-12-31 $990,536 17,002
2020-09-30 $1,263,926 20,002
2020-06-30 $1,593,504 20,711
2020-03-31 $1,391,956 18,619